Multidrug Resistance

References

• Schimke R T. Gene amplification, drug resistance, and cancer. Cancer Res 1984; 44: 3643–53
   PubMedGoogle Scholar
• Hall A, Cattan A R, Proctor S J. Mechanisms of drug resistance in acute leukaemia. Leuk Res 1989; 13: 351–6
   PubMedGoogle Scholar
• Beck W T. Multidrug resistance and its circumvention. Eur J Cancer 1990; 26: 513–5
   PubMedGoogle Scholar
• Larsen A K, Jacquemin-Sablon A. Multiple resistance mechanisms in Chinese hamster cells resistant to 9-hydroxy-ellipticine. Cancer Res 1989; 49: 7115–9
   PubMedGoogle Scholar
• Piller G J. Leukaemia research fund international research symposium on cytotoxi c drug resistance in leukemia and other malignancies. Leukemia 1989; 3: 461–7
   PubMed Web of Science ®Google Scholar
• Watson J D, Hopkins N H, Roberts J W, Steiz J A, Weiner A M. Molecular biology of the gene, edition. The Benjamin/Cummings Publishing Company, Inc., Menlo Park, CaliforniaUSA 1987; Vol. 1, 4
   Google Scholar
• Rice G C, Ling V, Schimke T. Frequencies of independent and simultaneous selection of Chinese hamster cells for methotrexate and doxorubicin (Adriamycin) resistance. Proc Natl Acad Sci USA 1987; 84: 9261–4
   PubMedGoogle Scholar
• Dalton W S. Mechanisms of drug resistance in breast cancer. Semin Oncol 1990; 174(suppl 7)37–9
   Google Scholar
• Waxman D J. Glutathione S-Transferases: Role in alkylating agent resistance and possible target for modulation chemotherapy-A review. Cancer Res 1990; 50: 6449–54
   PubMed Web of Science ®Google Scholar
• Kelley S L, Basu A, Teicher B A. Overexpression of metallothionein confers resistance to anticancer drugs. Science 1988; 241: 1813–5
   PubMed Web of Science ®Google Scholar
• Ma D DF, Bell D R. Multidrug resistance and P-glycoprotein expression in human cancer. Aust NZ J Med 1989; 19: 736–43
   PubMedGoogle Scholar
• Juliano R L, Ling V. A surfae glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152–62
   PubMed Web of Science ®Google Scholar
• Bell D R, Gerlach J H, Kartner J H, Buick R N, Ling V. Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. J Clin Oncol 1985; 3: 311–5
   PubMed Web of Science ®Google Scholar
• Volm M, Bak M, Mattern J. Intrinsic multidrug resistance in human lung carcinomas grown in nude mice. Strahlenter Onkol 1989; 165: 524–6
   PubMedGoogle Scholar
• Friche E, Skovsgaard T, Danø K. Multidrug resistance: Drug extrusion and its counteraction by chemosensitizers. Eur J Haematol 1989; 42((48))59–67
   Google Scholar
• Friedlander M L, Bell D, Leary J, Davey R A. Comparison of Western blot analysis and immunocytochemical detection of P-glycoprotein in multidrug resistant cells. J Clin Pathol 1989; 49: 719–22
   Google Scholar
• Gekeler V, Frese G, Diddens H, Probst H. Expression of a P-glycoprotein gene is inducible in a multidrug-resistant human leukemia cell line. Biochem Biophys Res Comm 1988; 155: 754–60
   PubMed Web of Science ®Google Scholar
• Endicott J, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistane. Ann Rev Biochem 1989; 58: 137–71
   PubMed Web of Science ®Google Scholar
• Choi K, Chen C, Kriegler M, Roninson I B. An altered pattern of cross-resistance in multidrug resistant human cells results from spontaneous mutations in the mdr-1 (P-glycoprotein) gene. Cell 1988; 53: 519–29
   PubMed Web of Science ®Google Scholar
• Van der Bliek A M, Borst P. Multidrug resistance. Adv Cancer Res 1989; 52: 165–203
   PubMed Web of Science ®Google Scholar
• Safa A R, Stern R K, Choi K, et al. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185 Val-185 substitution in P-glycoprotein. Proc Natl Acad Sci USA 1990; 87: 7225–9
   PubMed Web of Science ®Google Scholar
• Van der Bliek, Baas F, Van der Velde-Kroets T, et al. Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res 1988; 48: 5927–32
   PubMed Web of Science ®Google Scholar
• Bradley G, Juranka P F, Ling V. Mechanism of multidrug resistance. Biochim Biophys Acta 1988; 948: 87–128
   PubMed Web of Science ®Google Scholar
• Jongsma A PM, Spengler B A, Van der Bliek A M, Borst P, Biedler J L. Chromosomal localization of three genes coamplified in the multidrug-resistant CHrC5 Chinese hamster ovary cell line. Cancer Res 1987; 47: 2875–8
   PubMedGoogle Scholar
• Moscow J A, Fairchild C R, Madden M J, et al. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 1989; 49: 1422–8
   PubMed Web of Science ®Google Scholar
• Wang Y, Teicher B A, Shea T C, et al. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res 1989; 49: 6185–92
   PubMed Web of Science ®Google Scholar
• Moscow J A, Townsend A L, Goldsmith M E, et al. Isolation of the human anionic glutatione-S-transferase cDNA and the relation of its gene expression to estrogen-receptor content in primary breast cancer. Proc Natl Acad Sci USA 1988; 85: 6518–22
   PubMed Web of Science ®Google Scholar
• West I C. What determines the substrate specificity of the multi-drugresistance pump?. Trends Bioch Sci 1990; 15: 42–6
   PubMed Web of Science ®Google Scholar
• Mickisch G, Bier H, Bergler W, Bak M, Tschada R, Alken P. P-170 glycoprotein, glutathione and associated enzymes in relation to chemoresistance of primary human renal cell carcinomas. Urol Int 1990; 45: 170–6
   PubMedGoogle Scholar
• Ames G F-L. The basis of multidrug resistance in mammalian cells: Homology with bacterial transport. Cell 1986; 47: 323–4
   PubMed Web of Science ®Google Scholar
• Kane S E, Gottesmann M M. Meeting Review: Multidrug resistance in laboratory and clinic. Cancer Cells 1989; 1: 33–6
   PubMed Web of Science ®Google Scholar
• Chen C, Chin J E, Ueda K. Internal duplication and homology with bacterial transport proteins in the mdr-1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381–9
   PubMed Web of Science ®Google Scholar
• Van der Bliek A M, Kooiman P M, Schneider C, Borst P. Sequence of the mdr3 cDNA encoding a human P-glycoprotein. Gene 1988; 71: 401–11
   PubMed Web of Science ®Google Scholar
• Chen C, Chin J E, Clark D P, et al. Genomic organization of the human multidrug resistance (mdrl) gene and origin of P-glycoproteins. J Biol Chem 1990; 265: 506–14
   PubMed Web of Science ®Google Scholar
• Raymond M, Gros P. Mammalian multidrug-resistance gene: correlation of exon organization with structural domains and duplication of an ancestral gene. Proc Natl Acad Sci USA 1989; 86: 6488–92
   PubMedGoogle Scholar
• Van der Bliek A M, Baas F, Ten Houte de Lange T, et al. The human mdr3 gene encodes a novel P-glycoprotein homo-logue and gives rise to alternatively spliced mRNAs in liver. EMBO J 1987; 6: 3325–31
   PubMed Web of Science ®Google Scholar
• Kioka N, Tsubota J, Kakehi Y, et al. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altred pattern of multidrug resistance. Biochem Biophys Res Comm 1989; 162: 224–31
   PubMed Web of Science ®Google Scholar
• Herweijer H, Sonneveld P, Baas F, Nooter K. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 1990; 82: 1133–40
   PubMed Web of Science ®Google Scholar
• Nooter K, Sonneveld P, Janssen A, et al. Expression of the mdr3 gene in prolymphocytic leukemia: association with cyclosporin-A-induced increase in drug accumulation. Int J Cancer 1990; 45: 626–31
   PubMed Web of Science ®Google Scholar
• Gros P, Fallows D A, Croop J, Housman D E. Chromosome-mediated gene transfer of multidrug resistance. Mol Cell Biol 1986; 6: 3785–90
   PubMedGoogle Scholar
• Gerlach J H, Endicort J A, Juranka P F, et al. Homology between P-glycoprotein and a bacterial transport protein suggests a model for multidrug resistance. Nature 1986; 324: 485–9
   PubMed Web of Science ®Google Scholar
• McGrath J P, Varshavsky A. The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein. Nature 1990; 340: 400–4
   Google Scholar
• Foote S, Thompson J K, Cowman A F, Kemp D J. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P falciparum. Cell 1989; 57: 921–39
   PubMed Web of Science ®Google Scholar
• Wilson C M, Serrano A E, Wasley A, et al. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 1989; 244: 1184–6
   PubMed Web of Science ®Google Scholar
• Ueda K, Cardarelli C, Gottesman M M, Pastan I. Expression of a full-length cDNA for the human “MDR1” gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 1987; 84: 3004–8
   PubMed Web of Science ®Google Scholar
• Galski H, Sullivan M, Willingham M C, et al. Expression of a human multidrug resistance cDNA (mdrl) in the bone marrow of transgenic mice: Resistance to daunomycin-in-duced leukopenia. Mol Cell Biol 1989; 9: 4357–63
   PubMed Web of Science ®Google Scholar
• Georges E, Bradley G, Gariepy J, Ling V. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proc Natl Acad Sci USA 1990; 87: 152–6
   PubMed Web of Science ®Google Scholar
• Richert N, Aldwin L, Nitecki D, Gottesman M M, Pastan I. Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells. Biochemistry 1988; 27: 7607–13
   PubMed Web of Science ®Google Scholar
• Meyers M B, Rittman-Grauer L, O'Brien J P, Safa A R. Characterization of monoclonal antibodies recognizing a 180 kDa and 170kDa P-glycoproteins in multidrug-resistant human tumor cells. Cancer Res 1989; 49: 3209–14
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo O, O'Brien J P, Casals D, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989; 86: 695–8
   PubMed Web of Science ®Google Scholar
• Lieberman D M, Reithmeier R AF, Ling V, Charuk J M, Goldberg H, Skorecki K L. Identification of P-glycoprotein in renal brush border membranes. Biochem Biophys Res Comm 1989; 162: 244–52
   PubMed Web of Science ®Google Scholar
• Ueda K, Cornwell M M, Gottesman M M. The mdr1 gene, responsible for multidrug-resistance, codesfor P-glycoprotein. Biochem Biophys Res Comm 1986; 141: 956–62
   PubMed Web of Science ®Google Scholar
• Danø K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta 1973; 323: 466–83
   PubMed Web of Science ®Google Scholar
• Gros P, Croop J, Housman D. Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell 1986; 47: 371–80
   PubMed Web of Science ®Google Scholar
• Gros P, Raymond M, Bell J, Housman D E. Cloning and characterization of a second member of the mouse mdr gene family. Mol Cell Biol 1988; 8: 2770–8
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Kuwazuru Y, Sumlzawa T, et al. Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. J Biol Chem 1989; 264: 16282–91
   PubMed Web of Science ®Google Scholar
• Ames G F-L. Bacterial periplastic transport systems: structure, mechanism, and evolution. Ann Rev Biochem 1986; 55: 397–425
   PubMed Web of Science ®Google Scholar
• Currier S J, Ueda K, Willingham M C, Pastan I, Gottesman M M. Deletion and insertion mutants of the multidrug transporter. J Biol Chem 1989; 264: 14376–81
   PubMed Web of Science ®Google Scholar
• Bruggeman E P, Germann U A, Gottesman M M, Pastan I. Two different regions of P-glycoprotein are photoaffinity-labeled by azidopine. J Biol Chem 1989; 264: 15483–8
   PubMedGoogle Scholar
• Kamimoto Y, Gatmaitan Z, Hsu J, Arias I M. The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J Biol Chem 1989; 264: 11693–8
   PubMed Web of Science ®Google Scholar
• Azzaria M, Schurr E, Gros P. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdrl gene abolish its ability to confer multidrug resistance. Mol Cell Biol 1989; 9: 5289–97
   PubMed Web of Science ®Google Scholar
• Cornwell M M, Tsuruo T, Gottesman M M, Pastan I. ATP-binding properties of P-glycoprotein from multidrug-resistant KB cells. FASEB J 1987; 1: 51–4
   PubMed Web of Science ®Google Scholar
• Naito M, Tsuruo T. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement. Cancer Res 1989; 49: 1452–5
   PubMed Web of Science ®Google Scholar
• Staats J, Marquardt D, Center M S. Characterization of a membrane-associated protein kinase of multidrug-resistant HL 60 cells which phosphorylates P-glycoprotein. J Biol Chem 1990; 265: 4084–90
   PubMed Web of Science ®Google Scholar
• McGrath T, Center M S. Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug. Cancer Res 1988; 48: 63
   Google Scholar
• Chambers T C, Chalikonda I, Eilon G. Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem Biophys Res Comm 1990; 169: 253–9
   PubMedGoogle Scholar
• Mellado W, Horwitz S B. Phosphorylation of the multidrug resistance associated glycoprotein. Biochemistry 1987; 26: 6900–4
   PubMed Web of Science ®Google Scholar
• Dickson R B, Gottesman M M. Understanding of the molecular basis of drug resistance reveals new targets for chemotherapy. Trends Pharmacol Sci 1990; 11: 305–7
   PubMedGoogle Scholar
• Boscoboinick D, Debanne M T, Stafford A R, Jung C Y, Gupta R S, Epand R M. Dimerization of the P-glycoprotein in membranes. Biochim Biophys Acta 1990; 1027: 225–8
   PubMedGoogle Scholar
• Germann A, Willingham M C, Pastan I, Gottesman M M. Expression of the human multidrug transporter in insect cells by a recombinant baculovirus. Biochemistry 1990; 29: 2295–303
   PubMed Web of Science ®Google Scholar
• Bénard J, Da Silva J, Teyssier J-R, Riou G. Over-expression of mdrl gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line. Int J Cancer 1989; 43: 471–7
   PubMed Web of Science ®Google Scholar
• Roninson I B, Chin J E, Choi K, et al. Isolation of human MDR DNA sequences amplified in human multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci USA 1986; 83: 4538–42
   PubMed Web of Science ®Google Scholar
• Mickley L A, Bates S E, Richert N D, et al. Modulation of expression of a multidrug resistance gene (mdr1/P-glycoprotein) by differentiating agents. J Biol Chem 1989; 264: 18031–40
   PubMed Web of Science ®Google Scholar
• Bates S E, Mickley L A, Chen Y-N, et al. Expression of a drug resistance gene in human neuroblastoma cell lines: Modulation by retinoic acid-induced differentiation. Mol Cell Biol 1989; 9: 4337–44
   PubMed Web of Science ®Google Scholar
• Chin K-V, Tanaka S, Darlington G, Pastan I, Gottesman M M. Heat shock and aresenite increase expression of the multidrug resistance (MDR1) gene in human renal cells. J Biol Chem 1990; 265: 221–6
   PubMed Web of Science ®Google Scholar
• Thorgeirsson S S, Huber B E, Sorrell S, Fojo A, Pastan I, Gottesman M M. Expression of the multidrug resistant gene in hepatocarcinogenesis and regenerating rat liver. Science 1987; 236: 1120–1
   PubMed Web of Science ®Google Scholar
• Thiebaut F, Tsuruo T, Hamada H, Gottesman M M, Pastan I, Willingham M C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987; 84: 7735–8
   PubMed Web of Science ®Google Scholar
• Cordon-Cardo C, O'Brien J P, Boccia J, Casals D, Bertino J R, Melamed M R. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 1990; 38: 1277–87
   PubMed Web of Science ®Google Scholar
• Van der Valk P, van Kalken C K, Ketelaars H, et al. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues: Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule. Annals Oncol 1990; 1: 56–64
   PubMed Web of Science ®Google Scholar
• Sugawara I, Kataoka I, Morishita Y, et al. Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 1988; 48: 1926–9
   PubMed Web of Science ®Google Scholar
• Weinstein R S, Kuszak J R, Jakate S M, Lebovitz A B, Kluskens L F, Coon J S. ABO blood type predicts the cytolocalization of anti-P-glycoprotein monoclonal antibody reactivity in human colon and ureter. Hum Pathol 1990; 21(9)949–58
   PubMedGoogle Scholar
• Sugawara I, Nakahama M, Hamada H, Tsuruo T, Mori S. Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of Mr 170,000–180,000 P-glycoprotein. Cancer Res 1988; 48: 4611–4
   PubMed Web of Science ®Google Scholar
• Yang C-P H, De Pinho Goei S, Greenberger L M, Arceci R J, Horwitz S B. Progesterone interacts with P-glycoprotein in multidrug resistant cells and in the endometrium of gravid uterus. J Biol Chem 1989; 264: 782–8
   PubMed Web of Science ®Google Scholar
• Naito M, Yasa K, Tsuruo T. Steroid hormones inhibit binding of vinca alkaloid to multidrug resistance related P-glycoprotein. Biochem Biophys Res Comm 1989; 158: 1066–71
   PubMed Web of Science ®Google Scholar
• Arceci R J, Baas F, Raponi R, Horwitz S B, Housman D, Croop J M. Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Mol Reprod Dev 1990; 25: 101–9
   PubMed Web of Science ®Google Scholar
• Kacinski B M, Yee L D, Carter D, Li D, Kuo M T. Human breast carcinoma cell levels of mdr-1 (P-glycoprotein) transcripts correlate in vivo inversely and reciprocally with tumor progesterone receptor content. Cancer Commun 1989; 1: 1–6
   PubMedGoogle Scholar
• Gerlach J L, Bell D R, Karakousis C. P-glycoprotein in human sarcoma: evidence for multidrug resistance. J Clin Oncol 1987; 5: 1452–60
   PubMed Web of Science ®Google Scholar
• Goldstein L J, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancer. J Natl Cancer Inst 1989; 81: 116–24
   PubMed Web of Science ®Google Scholar
• Fojo A, Ueda K, Slamon D J, Poplack D G, Gottesman M M, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987; 84: 265–9
   PubMed Web of Science ®Google Scholar
• Mizoguchi T, Yamada K, Furukawa T, et al. Expression of the mdrl gene in human gastric and colorectal carcinomas. J Natl Cancer Inst 1990; 82: 1679–83
   PubMedGoogle Scholar
• Kanamaru H, Kakehi Y, Yoshida O, Nakanishi S, Pastan I, Gottesman M M. Mdr1 RNA levels in human renal cell carcinomas: Correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. J Natl Cancer Inst 1989; 81: 844–9
   PubMed Web of Science ®Google Scholar
• Bourhis J, Bénard J, Hartamann O, Boccon-Gibod L, Lemerle J, Riou G. Correlation of mdrl gene expression with chemotherapy in neuroblastoma. J Natl Cancer Inst 1989; 81: 1401–5
   PubMed Web of Science ®Google Scholar
• Rubin S C, Finstad C L, Hoskins W J, et al. Expression of P-glycoprotein in epithelial orvarian cancer: evaluation as a marker of multidrug resistance. Am J Obstet Gynecol 1990; 163: 69–73
   PubMed Web of Science ®Google Scholar
• Rutledge M L, Robey-Cafferty S S, Silva E G, Bruner J M. Monoclonal antibody C219 detection of the multidrug-resistant protein P-glycoprotein in routinely processed tissues: a study of 36 cases of ovarian carcinoma. Mod Pathol 1990; 3: 298–301
   PubMed Web of Science ®Google Scholar
• Volm M, Efferth T, Bak M, Ho A D, Mattern J. Detection of the multidrug resistance phenotype in human tumors by monoclonal antibodies and the streptavidin-biotinylated phycoerythrin complex method. Eur J Cancer Clin Oncol 1989; 25: 743–9
   PubMedGoogle Scholar
• Kohno K, Sato S-I, Takano H, Matsuo K-I, Kuwano M. The direct acivation of human multidrug resistance gene (mdrl) by anticancer agents. Biochem Biophys Res Comm 1989; 165: 1415–21
   PubMed Web of Science ®Google Scholar
• Hill B T, Deuchars K, Hosking L K, Ling V, Whelan R DH. Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro. J Natl Cancer Inst 1990; 82: 607–12
   PubMed Web of Science ®Google Scholar
• Goldstein L J, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116–24
   PubMed Web of Science ®Google Scholar
• Schlaifer D, Laurent G, Chittal S, et al. Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumor and stromal cells of human cancers. Br J Cancer 1990; 62: 177–82
   PubMed Web of Science ®Google Scholar
• Ro J, Sahin A, Fritsche H, Hortobagyi G, Blick M. Immunohistochemical analysis of P-giycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol 1990; 21: 787–91
   PubMed Web of Science ®Google Scholar
• Salmon S E, Grogan T M, Miller T, Scheper R, Dalton W S. Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining. J Natl Cancer Inst 1989; 81: 696–701
   PubMed Web of Science ®Google Scholar
• Ronchi E, Sanfilippo O, Di Fronzo G, et al. Detection of the 170 kDa P-glycoprotein in neoplastic and normal tissues. Tumori 1989; 75: 542–6
   PubMedGoogle Scholar
• Robey-Cafferty S S, Rutledge M L, Bruner J M. Expression of a multidrug resistance gene in esophageal adenocarcinoma: Correlation with response to chemotherapy and comparison with gastric adenocarcinoma. Am J Clin Pathol 1990; 93: 1–7
   PubMedGoogle Scholar
• Lai S-L, Goldstein L J, Gottesman M M, et al. Mdr1 gene expression in lung cancer. J Natl Cancer Inst 1989; 81: 1144–50
   PubMed Web of Science ®Google Scholar
• Radosevich J A, Robinson P G, Rittmann-Grauer L S, et al. Immunohistochemical analysis of pulmonary and pleural tumors with the monoclonal antibody HYB-612 directed against the multidrug resistance (mdrl) gene product, P-glycoprotein. Tumor Biol 1989; 10: 252–7
   PubMedGoogle Scholar
• Corrias M V, Cornaglia-Ferraris P, DiMartino D, et al. Expression of multiple drug resistance gene, mdrl, and N-myc oncogene in an italian population of human neuroblastoma patients. Anticanc Res 1990; 10: 897–902
   PubMedGoogle Scholar
• Bourhis J, Goldstein L, Riou G, Pastan I, Gottesman M M, Bénard J. Expression of a multidrug resistance gene in ovarian carcinomas. Cancer Res 1989; 49: 5062–5
   PubMed Web of Science ®Google Scholar
• Bak M, Jr, Efferth T, Mickisch G, Mattern J, Wolm M. Detection of drug resistance and P-glycoprotein in human renal cell carcinomas. Eur Urol 1990; 17: 72–5
   PubMedGoogle Scholar
• Thiebaut F, Tsuruo T, Hamada H, Gottesman M M, Pastan I, Willingham M C. Immunohistochemical epitopes in the multidrug transporter protein P-170. J Histochem Cytochem 1989; 37: 159–64
   PubMed Web of Science ®Google Scholar
• Merkel D E, Fuqua S AW, Tandon A K, Hill S M, Buzdar A U, McGuire W L. Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification. J Clin One 1989; 7: 1129–36
   PubMed Web of Science ®Google Scholar
• Chan H SL, Throner P S, Haddad G, Ling V. Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990; 8: 689–704
   PubMed Web of Science ®Google Scholar
• Schwartsmann G, Cerski C T, Sander E, Sprinz E, Kronfeld M. P-glycoprotein expression and AIDS-related Kaposi's sarcoma (letter). J Natl Cancer Inst 1989; 81: 1755–6
   PubMedGoogle Scholar
• Holmes J, Jacobs A, Carter G, Janowska-Wieczorek A, Padua R A. Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myoeloblastic leukaemia. Br J Haematol 1989; 72: 40–4
   PubMed Web of Science ®Google Scholar
• Musto P, Cascavilla N, DiRenzo N, et al. Clinical relevance of immunocytochemical detection of multidrug-resistance-associated P-glycoprotein in hematologic malignancies. Tumori 1990; 76: 353–9
   PubMed Web of Science ®Google Scholar
• Sugawara I, Kodo H, Ohkochi E, Hamada H, Tsuruo T, Mori S. High-level expression of MRK16 and MRK 20 murine monoclonal antibody-defined proteins (170,000–180,000 P-glycoprotein and 85,000 protein) in leukaemias and malignant lymphomas. Br J Cancer 1989; 60: 538–41
   PubMed Web of Science ®Google Scholar
• Mattem J, Efferth T, Bak M, Ho A D, Volm M. Detection of P-glycoprotein in human leukemias using monoclonal antibodies. Blut 1989; 58: 215–7
   PubMedGoogle Scholar
• Sato H, Gottesman M M, Goldstein L J, et al. Expression of the multidrug resistance gene in myeloid leukemias. Leuk Res 1990; 14: 11–22
   PubMed Web of Science ®Google Scholar
• Sato H, Presiler H, Day R, et al. Mdr1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia. Br J Haematol 1990; 75: 340–5
   PubMed Web of Science ®Google Scholar
• Musto P, Melillo L, Lombardi G, Matera R, DiGiorgio G, Carotenuto M. High risk of early resistant relapse for leukaemic patient with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission. Br J Haematol 1991; 77: 50–3
   PubMed Web of Science ®Google Scholar
• Kuwazuru Y, Hanada S, Furukawa T, et al. Expression of P-glycoprotein in adult T-cell leukemia cells. Blood 1990; 10: 2065–71
   Google Scholar
• Ma D DF, Davey R A, Harman D H, et al. Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukemia. Lancet 1987; 1: 135–7
   PubMed Web of Science ®Google Scholar
• Nooter K, Sonneveld P, Oostrum R, Herweijer H, Hagenbeek T, Valerio D. Overexpression of the mdrl gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A. Int J Cancer 1990; 45: 263–8
   PubMed Web of Science ®Google Scholar
• Kuwazuru Y, Yoshimura A, Hanada S, et al. Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis. Br J Haematol 1989; 74: 24–9
   Google Scholar
• Rothenberg M L, Mickley L A, Cole D E, et al. Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. Blood 1989; 74: 1388–95
   PubMed Web of Science ®Google Scholar
• Kato S, Nishimura J, Muta K, Yufu Y, Nawata H, Ideguchi H. Overexpression of P-glycoprotein in adult T-cell leukaemia. Lancet 1990; 336: 573
   PubMed Web of Science ®Google Scholar
• Holmes J A, Jacobs A, Carter G, Whittaker J A, Bentley D P, Padua R A. Is the mdr1 gene relevant in chronic lymphocytic leukemia?. Leukemia 1990; 4: 216–8
   PubMed Web of Science ®Google Scholar
• Cumber P M, Jacobs A, Hoy T, et al. Expression of the multiple drug resistance gene (mdr-1) and epitope masking in chronic lymphatic leukaemia. Br J Haematol 1990; 76: 226–30
   PubMed Web of Science ®Google Scholar
• Dalton W S, Grogan T M, Rybski J A, et al. Immun-ohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: Association with level of drug resistance and drug accumulation. Blood 1989; 73: 747–52
   PubMed Web of Science ®Google Scholar
• Dalton W S, Grogan T M, Meltzer P S, et al. Drug-resistance in multiple myeoloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 1989; 7: 415–24
   PubMed Web of Science ®Google Scholar
• Epstein J, Xiao H, Oba B K. P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD. Blood 1989; 74: 913–7
   PubMed Web of Science ®Google Scholar
• Kuwazuru Y, Yoshimura A, Hanada S, et al. Expression of the multidrug transporter, P-glycoprotein in acute leukemia cells and correlation to clinical drug resistance. Cancer 1990; 66: 868–73
   PubMed Web of Science ®Google Scholar
• Holmes J A, West R R, Whittaker J A, Jacobs A. Correlation of MDR status with clinical outcome in patients with acute myeloblastic leukaemia. Br J Haem 1991; 77: 130–1
   PubMedGoogle Scholar
• Croop J M, Raymond M, Haber D, et al. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol 1989; 9: 1346–50
   PubMed Web of Science ®Google Scholar
• Baas F, Borst P. The tissue dependent expression of hamster P-glycoprotein genes. FEBS Lett 1988; 229: 329–32
   PubMed Web of Science ®Google Scholar
• Chin J E, Soffir R, Noonan K E, Choi K, Roninson I B. Structure and expression of the human MDR (P-glycoprotein) gene family. Mol Cell Biol 1989; 9: 3808–20
   PubMed Web of Science ®Google Scholar
• Murphy L D, Herzog C E, Rudick J B, Fojo A T, Bates S E. Use of polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry 1990; 29: 10351–6
   PubMed Web of Science ®Google Scholar
• Kartner N, Evernden-Porelle D, Bradley G, Ling V. Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 1983; 316: 820–3
   Web of Science ®Google Scholar
• Scheper R J, Bulte J WM, Brakkee J GP, et al. Monoclonal antibody JSB-1 detects a higly conserved epitope on the P-glycoprotein associated with multidrug resistance. Int J Cancer 1988; 42: 389–94
   PubMed Web of Science ®Google Scholar
• Hamada H, Tsuruo T. Functional role for the 170- to 180-kDa glycoprotein spesific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 1986; 83: 7785–9
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Iida H, Nojri M, Tsukagoshi S, Sakurai Y. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 1981; 41: 1967–72
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Lida H, Nojri M, Tsukagoshi S, Sakurai Y. Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 1983; 43: 2905–10
   PubMed Web of Science ®Google Scholar
• Mickisch G H, Kössig J, Keilhauer G, Schlick E, Tschada R K, Alken P M. Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas. Cancer Res 1990; 50: 3670–4
   PubMedGoogle Scholar
• Pirker R, Keilhauer G, Raschack M, Lechner C, Ludwig H. Reversal of multi-drug resistance in human KB cell lines by structural analogs of verapamil. Int J Cancer 1990; 45: 916–9
   PubMed Web of Science ®Google Scholar
• Keizer H G, Joenje H. Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil. J Natl Cancer Inst 1989; 81: 706–9
   PubMedGoogle Scholar
• Gavériaux C, Boesch D, Boelsterli J J, et al. Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosupressive derivatives. Br J Cancer 1989; 60: 867–71
   PubMed Web of Science ®Google Scholar
• Sonneveld P, Nooter K. Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemia. Br J Haematol 1990; 75: 208–11
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Hamada H, Sato S, Heike Y. Inhibition of multidrug-resistant human tumor growth in athymic mice by anti-P-glycoprotein monoclonal antibodies. Jpn J Cancer Res 1989; 80: 627–31
   PubMedGoogle Scholar
• Dinota A, Tazzari P L, Michieli M, et al. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody. Cancer Res 1990; 50: 4291–4
   PubMed Web of Science ®Google Scholar
• Kulkami S S, Wang Z, Spitzer G, et al. Elimination of drug-resistant myeloma tumor cell lines by monoclonal anti-P-glycoprotein antibody and rabbit complement. Blood 1989; 74: 2244–51
   PubMedGoogle Scholar
• FitzGerald D J, Willingham M C, Cardarelli C O, et al. A monoclonal antibody-pseudomonas toxin conjugate that specifically kills multidrug-resistant cells. Proc Natl Acad Sci USA 1987; 84: 4288–92
   PubMed Web of Science ®Google Scholar
• Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Cancer Res 1989; 49: 5537–42
   PubMed Web of Science ®Google Scholar